• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Model Number S0508
Device Problem Material Integrity Problem (2978)
Patient Problems Seroma (2069); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/15/2021
Event Type  Injury  
Manufacturer Narrative
It was stated that the device is available for investigation, but was not yet returned.Patient details (age and weight) were requested but not provided.Evaluation codes investigation findings 213 refers to the phr.A review of the manufacturing records indicated the lots met all pre-release specifications.
 
Event Description
It was reported that the patient underwent surgical treatment for a fistula in the arm with a gore-tex® stretch vascular graft non-ringed.It was stated that on (b)(6) 2021 the physician implanted a gore-tex® stretch vascular graft to reduce the blood flow of a fistula.Some days later the patient presented with a lymphocele.It was reported that a re-intervention took place on (b)(6) 2021 to drain the lymphocele.Hereby the physician realized that the wall of the graft was permeable all along.It was stated that the physician decided to replace the graft which was performed on (b)(6) 2021.The patient tolerated the procedure.
 
Manufacturer Narrative
Explant investigation: a fragment was returned to w.L.Gore & associates for investigation.Submitted in formalin was a gore-tex stretch vascular graft fragment.The device fragment had been transected, prior to arrival at w.L.Gore and associates.The abluminal surface was generally devoid of tissue, except for scattered, plagues of tan/brown tissue.The lumen was generally devoid of tissue, with small fragments of white/tan to red/brown gelatinous tissue scattered on the luminal surface.The lumen was widely patent.Histopathological examination of one transverse section was performed.The gross and microscopic observations of proteinaceous fluid within the eptfe graft interstices and acellular protein coagulum on the abluminal surface was consistent with the clinical assessment of graft seroma.There was no evidence of inflammation or collagenous organization within the graft or abluminal coagulum.The fragment was subjected to an enzymatic digestion process to remove biologic debris.Following digestion, the fragment was examined for material disruptions with the aid of a stereomicroscope.The material disruptions identified were consistent with interaction with surgical instrumentation, likely used during a surgical procedure.Disruptions identified were not associated with handling or manufacturing process at w.L.Gore & associates.The disruptions are consistent with a surgical procedure.No disruptions that would contribute to seroma were identified on the returned fragment.The cause of the seroma could not be determined with the information provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX® STRETCH VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12702589
MDR Text Key278532134
Report Number2017233-2021-02490
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00733132611256
UDI-Public00733132611256
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K903931
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/27/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberS0508
Device Catalogue NumberS0508
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/01/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/30/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-